These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9261108)

  • 1. Production of a specific major histocompatibility complex class I-restricted epitope by ubiquitin-dependent degradation of modified ovalbumin in lymphocyte lysate.
    Ben-Shahar S; Cassouto B; Novak L; Porgador A; Reiss Y
    J Biol Chem; 1997 Aug; 272(34):21060-6. PubMed ID: 9261108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 26 S proteasome-mediated production of an authentic major histocompatibility class I-restricted epitope from an intact protein substrate.
    Ben-Shahar S; Komlosh A; Nadav E; Shaked I; Ziv T; Admon A; DeMartino GN; Reiss Y
    J Biol Chem; 1999 Jul; 274(31):21963-72. PubMed ID: 10419519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide.
    Heeg K; Kuon W; Wagner H
    Eur J Immunol; 1991 Jun; 21(6):1523-7. PubMed ID: 1904363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
    López D; Gil-Torregrosa BC; Bergmann C; Del Val M
    J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The specificity of proteasomes: impact on MHC class I processing and presentation of antigens.
    Niedermann G; Geier E; Lucchiari-Hartz M; Hitziger N; Ramsperger A; Eichmann K
    Immunol Rev; 1999 Dec; 172():29-48. PubMed ID: 10631935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced delivery of exogenous peptides into the class I antigen processing and presentation pathway.
    De Haan L; Hearn AR; Rivett AJ; Hirst TR
    Infect Immun; 2002 Jun; 70(6):3249-58. PubMed ID: 12011020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.
    Lucchiari-Hartz M; van Endert PM; Lauvau G; Maier R; Meyerhans A; Mann D; Eichmann K; Niedermann G
    J Exp Med; 2000 Jan; 191(2):239-52. PubMed ID: 10637269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.
    Rock KL; Gramm C; Rothstein L; Clark K; Stein R; Dick L; Hwang D; Goldberg AL
    Cell; 1994 Sep; 78(5):761-71. PubMed ID: 8087844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
    Maecker HT; Umetsu DT; DeKruyff RH; Levy S
    J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules.
    Niedermann G; Butz S; Ihlenfeldt HG; Grimm R; Lucchiari M; Hoschützky H; Jung G; Maier B; Eichmann K
    Immunity; 1995 Mar; 2(3):289-99. PubMed ID: 7535183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restricted ovalbumin determinant.
    Nikolić-Zugić J; Carbone FR
    Eur J Immunol; 1990 Nov; 20(11):2431-7. PubMed ID: 2253683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the ubiquitin-proteasome pathway in MHC class I antigen processing: implications for vaccine design.
    Sijts A; Zaiss D; Kloetzel PM
    Curr Mol Med; 2001 Dec; 1(6):665-76. PubMed ID: 11899255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of class I MHC-restricted, peptide-specific cytolytic T lymphocytes by peptide priming in vivo.
    Ishioka GY; Colon S; Miles C; Grey HM; Chesnut RW
    J Immunol; 1989 Aug; 143(4):1094-100. PubMed ID: 2787356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site.
    Beekman NJ; van Veelen PA; van Hall T; Neisig A; Sijts A; Camps M; Kloetzel PM; Neefjes JJ; Melief CJ; Ossendorp F
    J Immunol; 2000 Feb; 164(4):1898-905. PubMed ID: 10657639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.
    van Hall T ; Sijts A; Camps M; Offringa R; Melief C; Kloetzel PM; Ossendorp F
    J Exp Med; 2000 Aug; 192(4):483-94. PubMed ID: 10952718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues.
    Chen W; Khilko S; Fecondo J; Margulies DH; McCluskey J
    J Exp Med; 1994 Oct; 180(4):1471-83. PubMed ID: 7523572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proteolytic fragments generated by vertebrate proteasomes: structural relationships to major histocompatibility complex class I binding peptides.
    Niedermann G; King G; Butz S; Birsner U; Grimm R; Shabanowitz J; Hunt DF; Eichmann K
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8572-7. PubMed ID: 8710912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation.
    Wick MJ; Pfeifer JD
    Eur J Immunol; 1996 Nov; 26(11):2790-9. PubMed ID: 8921970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides.
    Carbone FR; Moore MW; Sheil JM; Bevan MJ
    J Exp Med; 1988 Jun; 167(6):1767-79. PubMed ID: 2455012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.